The Japanese Ministry of Health, Labour and Welfare has approved Takeda Pharmaceutical‘s Orzeyful (oveporexton) for adults with type 1…
Patricia Inacio PhD
Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Inacio PhD
In a small early clinical trial, single doses of the oral therapy alixorexton were found to be generally well…
A previously healthy 42-year-old woman in Europe developed type 1 narcolepsy with cataplexy — sudden episodes of muscle weakness…